Defining effective durations of antibiotic therapy for community-acquired pneumonia and urinary tract infections in hospitalized children

被引:4
|
作者
Wingler, Mary Joyce B. [1 ]
Tamma, Pranita D. [2 ]
机构
[1] Univ Mississippi, Dept Antimicrobial Stewardship, Med Ctr, 2500 N State St, Jackson, MS 39216 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
关键词
antibiotic stewardship; community-acquired pneumonia; pediatric; urinary tract infection; ACUTE UNCOMPLICATED CYSTITIS; LEVOFLOXACIN; 750; MG; SHORT-COURSE CIPROFLOXACIN; SINGLE-DOSE FOSFOMYCIN; DOUBLE-BLIND; OPEN-LABEL; TRIMETHOPRIM-SULFAMETHOXAZOLE; AMOXICILLIN-CLAVULANATE; ACUTE PYELONEPHRITIS; LORACARBEF LY163892;
D O I
10.1097/QCO.0000000000000857
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review Community-acquired pneumonia (CAP) and urinary tract infections (UTI) are two common childhood infections often leading to hospital admission. National guidelines for CAP and UTI in children recommend durations of antibiotic therapy of 10 days and 7-14 days, respectively. Due to concerns of rising antimicrobial resistance and an increased awareness of harms associated with prolonged courses of antibiotics, there is a renewed emphasis on reevaluating commonly prescribed durations of antibiotic therapy across bacterial infections. We describe recent clinical trials and observational studies evaluating durations of therapy for CAP and UTI in adults and children and translate the findings to our suggested approach for selecting durations of antibiotic therapy in hospitalized children. Recent findings There is a growing body of evidence, primarily in adults, that shorter durations of therapy than are commonly prescribed are just as effective as longer durations for CAP and UTIs. Combining clinical trial data from adults with available data in children, we believe it is reasonable to consider 5 days of therapy for CAP, 3-5 days of therapy for cystitis, and 7 days of therapy for pyelonephritis for most hospitalized children with uncomplicated infections.
引用
收藏
页码:442 / 451
页数:10
相关论文
共 50 条
  • [21] Management of Community-Acquired Pneumonia in Hospitalized Children
    Laura H. Simon
    Kavita Parikh
    Derek J. Williams
    Mark I. Neuman
    Current Treatment Options in Pediatrics, 2015, 1 (1) : 59 - 75
  • [22] The Management of Community-Acquired Pneumonia in Hospitalized Children
    Robertson, Gervin
    Richards, Tamara
    Renaud, Amy
    Holmes, Madison
    Thervil, Willineza
    US PHARMACIST, 2023, 48 (08) : HS2 - HS10
  • [23] Community-acquired enterococcal urinary tract infections
    Maria Bitsori
    Sofia Maraki
    Maria Raissaki
    Anna Bakantaki
    Emmanouil Galanakis
    Pediatric Nephrology, 2005, 20 : 1583 - 1586
  • [24] Community-acquired enterococcal urinary tract infections
    Bitsori, M
    Maraki, S
    Raissaki, M
    Bakantaki, A
    Galanakis, E
    PEDIATRIC NEPHROLOGY, 2005, 20 (11) : 1583 - 1586
  • [25] Treatment with appropriate antibiotic therapy in community-acquired respiratory tract infections
    Nicolau, DP
    AMERICAN JOURNAL OF MANAGED CARE, 2004, 10 (12): : S381 - S388
  • [26] Antibiotic Use and Outcomes in Young Children Hospitalized With Uncomplicated Community-Acquired Pneumonia
    Hofto, Meghan E.
    Samuy, Nichole
    Pass, Robert F.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (04):
  • [27] Monitoring of antibiotic therapy in Acute Respiratory Infections (ARIs) complicated with community-acquired pneumonia in children
    Turdalina, B.
    Seydullayeva, A.
    Shaidarov, M.
    Bayesheva, D.
    Kushugulova, A.
    Sujith, C.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 53 : 51 - 52
  • [28] Trends in Prescribing Antibiotic Therapy for Hospitalized Patients with Community-Acquired Pneumonia in Vietnam
    Tuan Huynh Anh Phan
    Thoai Dang Nguyen
    Tram Thi Huyen Nguyen
    Trung Quang Vo
    Thao Thi Quy Le
    Tro Van Chau
    Sy Van Hoang
    ARCHIVES OF PHARMACY PRACTICE, 2020, 11 (01) : 14 - 21
  • [29] Antibiotic resistance in community-acquired urinary tract infections: Prevalence and risk factors
    Kurtaran, Behice
    Candevir, Aslihan
    Tasova, Yesim
    Kibar, Filiz
    Inal, Ayse Seza
    Komur, Suheyla
    Aksu, Hasan Salih Zeki
    MEDICAL SCIENCE MONITOR, 2010, 16 (05): : CR246 - CR251
  • [30] Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections
    Kang, Cheol-In
    Kim, Jieun
    Park, Dae Won
    Kim, Baek-Nam
    Ha, U-Syn
    Lee, Seung-Ju
    Yeo, Jeong Kyun
    Min, Seung Ki
    Lee, Heeyoung
    Wie, Seong-Heon
    INFECTION AND CHEMOTHERAPY, 2018, 50 (01): : 67 - 100